Harbin Gloria Pharmaceuticals Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Harbin Gloria Pharmaceuticals Co., Ltd.
Wellness Industry News: Acting FDA Commissioner Named, Thorne Test Line Grows, Nitrosigine In Revel Energy, More
NCI's Sharpless named acting FDA head; Mannatech trims loss as costs grow; Nilo drinks to avoiding hangovers; Daoust leads Soylent Nutrition development, innovation; Viactiv in taller, narrower package; Revel Energy made with Nitrosigine; and Thorne has at-home tests for additional concerns.
Common thread between the manufacturers and retail chain operators offering their own and other brands extends to relatively recent executive suite shakeups following extended stretches of declining sales growth. GNC reported nearly $70m net income for 2018 after two years of net losses and Vitamin Shoppe trimmed its loss by more than $200m from 2017 to $12.1m.
GNC gets $150m investment from Harbin Pharmaceutical and launches e-commerce JV in China; Apple Rush adds NFL great Leonard Marshall to board; Children's bars from This Bar Saves Lives; USP hosts supplement stakeholder forum May 15; and more news.
CEO Ken Martindale says research and development linked to firm’s loyalty program, which provides data on the needs of the nearly 15m customers enrolled. “The data-driven insight we gain from our loyalty program are beginning to help us shape our product development and innovation,” he says.
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
- Other Names / Subsidiaries
- Guangzhou Gloria Biosciences Co., Ltd.
- Yu Heng Pharmaceutical
- Shanghai Huatuo
- Ono (china)
- Harbin Dandelion Pharmaceutical Co., Ltd.,
- Harbin Yuheng Jingwei Pharmaceutical Development Co., Ltd.
- Pude Pharmaceutical, Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.